Cite
HARVARD Citation
Nutman, A. et al. (2020). Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes. Clinical microbiology and infection. pp. 1185-1191. [Online].